Skip to main content
HairCited

비타민D 관련 여성형 탈모증

A 근거 여러 대규모 임상 시험이 일관되게 유의미한 효과를 보여줍니다.

총 15,494명의 참여자를 대상으로 한 18건의 연구(메타분석 2건)에 근거합니다. 연구 결과는 혼재되어 있습니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

Research shows that women with pattern hair loss often have lower vitamin D levels, but supplementing with vitamin D alone is unlikely to significantly improve this condition — it may be one supportive factor among many.

  • Lower vitamin D levels are consistently found in women with pattern hair loss
  • Supplementation alone is less effective than established options like minoxidil
  • Vitamin D receptor gene variants may influence susceptibility
  • Maintaining adequate vitamin D may support overall hair health but is not a standalone solution

Key Study Findings

narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None vs: Placebo 효과: None None
Meta-analysis
Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis.
Dose: None vs: Placebo 효과: OR=2.84 (AA vs controls), OR=5.24 (FPHL vs controls) p<0.01
cross-sectional observational n=120
Filling the Gaps: Vitamin D Status in Diffuse Hair Fall Among Pakistanis.
Dose: None vs: Placebo 효과: 79.17% of patients with diffuse hair fall were vitamin D3 deficient (mean 17.33 ± 5.43 ng/mL) None
meta_analysis n=10670
Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis.
Dose: not applicable (observational meta-analysis) vs: Placebo 효과: WMD -7.29 ng/mL (95% CI -9.21, -5.38); OR for vitamin D deficiency 3.11 (95% CI 2.29, 4.22) not explicitly stated; CI does
Case-control n=165
The development of non-scarring alopecia in women who wear the hijab.
Dose: None vs: Placebo 효과: OR=4.1 (95% CI 1.2-14.1) for vitamin D deficiency and telogen effluvium p=0.02
Other
Serum ferritin and vitamin D levels in women with non-scarring alopecia.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: Women with non-scarring alopecia

Key Statistics

19

연구

15494

참여자

Mixed

A

등급

Referenced Papers

Archives of dermatological … 2023 3 인용
Journal of cosmetic … 2021 44 인용
International journal of … 2017 61 인용
International journal of … 2016 42 인용
Skin pharmacology and … 2013 127 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
600-800 IU/day
deficiency:
1,000-5,000 IU/day

상한량: 4,000 IU/day

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive --
None -- Negative --
None -- Neutral 120
not applicable (observational meta-analysis) -- Negative 10670
None -- Positive 165
None -- Mixed --
None -- Negative --
1000 IU vitamin D3 daily 16 weeks Positive 2

권장 복용 시간: With a fat-containing meal for optimal absorption

Safety & Side Effects

보고된 부작용

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

알려진 상호작용

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)

일일 최대 섭취 허용량: 4,000 IU/day

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 비타민D help with 여성형 탈모증?
Based on 19 studies with 15,494 participants, there is strong evidence from multiple clinical trials that 비타민D may support 여성형 탈모증 management. Our evidence grade is A (Strong Evidence).
How much 비타민D should I take for 여성형 탈모증?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 비타민D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 비타민D and 여성형 탈모증?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 19 peer-reviewed studies with 15,494 total participants. The overall direction of effect is mixed.

References

  1. [1] Adam Leavitt et al.. J Drugs Dermatol. 2025. Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions. doi:10.36849/JDD.8763 PubMed
  2. [2] Yuling Chen et al.. J Cosmet Dermatol. 2024. Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis. doi:10.1111/jocd.16093 PubMed
  3. [3] Tanat Yongpisarn et al.. Front Nutr. 2024. Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis. doi:10.3389/fnut.2024.1479337 PubMed
  4. [4] Palwasha Jalil et al.. Dermatol Pract Concept. 2024. Filling the Gaps: Vitamin D Status in Diffuse Hair Fall Among Pakistanis. doi:10.5826/dpc.1404a232 PubMed
  5. [5] Marissa S Ceresnie et al.. Arch Dermatol Res. 2023. The development of non-scarring alopecia in women who wear the hijab. doi:10.1007/s00403-023-02713-3 PubMed
  6. [6] Ghada F R Hassan et al.. J Cosmet Dermatol. 2022. Treatment with oral vitamin D alone, topical minoxidil, or combination of both in patients with female pattern hair loss: A … doi:10.1111/jocd.14743 PubMed
  7. [7] Marina de Queiroz et al.. J Cosmet Dermatol. 2022. Serum ferritin and vitamin D levels in women with non-scarring alopecia. doi:10.1111/jocd.14472 PubMed
  8. [8] Kriteeka Saini et al.. J Cosmet Dermatol. 2021. Role of vitamin D in hair loss: A short review. doi:10.1111/jocd.14421 PubMed
  9. [9] Sarita Sanke et al.. Int J Dermatol. 2020. Study of serum vitamin D levels in men with premature androgenetic alopecia. doi:10.1111/ijd.14982 PubMed
  10. [10] Jun Zhao et al.. J Cosmet Dermatol. 2020. Serum 25 hydroxyvitamin D levels in alopecia areata, female pattern hair loss, and male androgenetic alopecia in a Chinese population. doi:10.1111/jocd.13396 PubMed
  11. [11] Erika Titus-Lay et al.. Ment Health Clin. 2020. Trichotillomania associated with a 25-hydroxy vitamin D deficiency: A case report. doi:10.9740/mhc.2020.01.038 PubMed
  12. [12] Iman Seleit et al.. Indian J Dermatol. 2020. Vitamin D Receptor Gene Polymorphisms Taq-1 and Cdx-1 in Female Pattern Hair Loss. doi:10.4103/ijd.IJD_482_18 PubMed
  13. [13] Enrico Carmina et al.. J Clin Endocrinol Metab. 2019. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. doi:10.1210/jc.2018-02548 PubMed
  14. [14] Kavita Poonia et al.. J Cosmet Dermatol. 2019. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. doi:10.1111/jocd.12559 PubMed
  15. [15] Silke Redler et al.. Exp Dermatol. 2017. Genetics and other factors in the aetiology of female pattern hair loss. doi:10.1111/exd.13373 PubMed
  16. [16] Agnieszka Gerkowicz et al.. Int J Mol Sci. 2017. The Role of Vitamin D in Non-Scarring Alopecia. doi:10.3390/ijms18122653 PubMed
  17. [17] Mahnaz Banihashemi et al.. Int J Trichology. 2016. Serum Vitamin D3 Level in Patients with Female Pattern Hair Loss. doi:10.4103/0974-7753.188965 PubMed
  18. [18] Tee Wei Siah et al.. Int J Trichology. 2016. Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. doi:10.4103/0974-7753.188033 PubMed
  19. [19] H Rasheed et al.. Skin Pharmacol Physiol. 2013. Serum ferritin and vitamin d in female hair loss: do they play a role? doi:10.1159/000346698 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.